Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...

Investment analysts at William Blair reduced their FY2025 earnings per share estimates for Amgen in a report released on Wednesday, February 5th. William Blair analyst M. Phipps now anticipates that ...

SOUTH SAN FRANCISCO, Calif. - Alumis Inc. (NASDAQ: ALMS), currently valued at $388 million and trading near its 52-week low of $6.29, and ACELYRIN, INC. (NASDAQ: SLRN) have entered into a definitive ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic arthritis, according to data published in Therapeutic Advances in Musculoskeletal ...

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...

An expert answers questions about physical therapy for psoriatic arthritis, from what to look for in a provider to what to ...

SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...

Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...

Arthritis affects millions of people, yet there’s a dearth of recommendations on exactly what products can help people manage ...